HALOZYME THERAPEUTICS, INC. Quarterly Goodwill in USD from Q4 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary: Halozyme Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2021 to Q2 2024.
Halozyme Therapeutics, Inc. Goodwill for the quarter ending June 30, 2024 was $417M, unchanged year-over-year.

Goodwill, Quarterly (USD)

Goodwill, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$417M	$0	0%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$417M	+$598K	+0.14%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$417M	+$7.77M	+1.9%	Dec 31, 2023	10-Q	2024-08-06
Q3 2023	$417M	+$217M	+109%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$417M	+$217M	+109%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$416M			Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$409M	+$409M		Dec 31, 2022	10-K	2024-02-20
Q3 2022	$199M			Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$199M			Jun 30, 2022	10-Q	2022-08-09
Q4 2021	$0			Dec 31, 2021	10-K	2023-02-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.